$524 Million is the total value of Adelphi Capital LLP's 3 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% . Adelphi Capital LLP is a registered-investment adviser.
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FIS | Sell | FIDELITY NATL INFORMATION SV | $255,859,000 | +4.3% | 1,839,518 | -0.4% | 48.86% | -7.8% |
TAK | Sell | TAKEDA PHARMACEUTICAL CO LTsponsored ads | $176,757,000 | +14.3% | 8,958,784 | -0.4% | 33.75% | +1.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-01-22
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
RYANAIR HLDGS PLC | 26 | Q2 2022 | 43.5% |
LIBERTY GLOBAL PLC | 15 | Q2 2018 | 97.1% |
FIDELITY NATL INFORMATION SV | 12 | Q2 2022 | 66.8% |
TAKEDA PHARMACEUTICAL CO LT | 8 | Q4 2020 | 39.1% |
WORLDPAY INC | 6 | Q2 2019 | 77.6% |
RYANAIR HLDGS PLC | 5 | Q4 2015 | 6.5% |
META PLATFORMS INC | 3 | Q3 2023 | 65.6% |
GALLAGHER ARTHUR J & CO | 3 | Q3 2023 | 34.6% |
MONDELEZ INTL INC | 1 | Q4 2022 | 36.8% |
DOLLAR GEN CORP NEW | 1 | Q4 2022 | 22.2% |
View Adelphi Capital LLP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-10-26 |
13F-HR | 2023-08-14 |
13F-HR | 2023-04-21 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-02 |
13F-HR | 2022-08-04 |
13F-HR | 2022-05-11 |
13F-HR | 2022-01-26 |
13F-HR | 2021-10-26 |
13F-HR | 2021-07-28 |
View Adelphi Capital LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.